Recent Quotes
My Watchlist
Indicators
Cabling Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

5.170 +0.140 (+2.78%)
Streaming Delayed Price Updated: 12:07 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
Q1 Earnings Outperformers: Evolent Health (NYSE:EVH) And The Rest Of The Healthcare Technology for Providers Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who didn’t). Let’s take a look at how healthcare technology ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Is Privia Health Stock a Buy After Hedge Fund Rubicon Founders Added Over 175,000 Shares to Its Position? ↗
Privia Health Group delivers technology-driven solutions to optimize physician practices and support value-based care nationwide. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Healthcare Stocks We Approach with Caution
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-... 
Via StockStory
Evolent Health Inc - A (NYSE:EVH) Q1 Revenue Miss Overshadowed by EPS Beat ↗
Via Chartmill
Evolent Health Inc - A (NYSE:EVH) Reports Q4 Earnings Beat Amid Revenue Decline, Issues Bullish 2026 Guidance ↗
Via Chartmill
Topics Earnings
News headline image
3 Reasons EVH is Risky and 1 Stock to Buy Instead
Over the last six months, Evolent Health’s shares have sunk to $3.96, producing a disappointing 5.7% loss - a stark contrast to the S&P 500’s 9.1% gain. This... 
Via StockStory
Topics Bankruptcy Stocks
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,... 
Via StockStory
News headline image
Evolent Health Q1 Earnings Call Highlights ↗
Evolent Health (NYSE:EVH) reported first-quarter 2026 results that management said were in line with expectations, while reiterating its full-year outlook and highlighting new contract wins, early... 
Via MarketBeat
Topics Earnings
News headline image
Evolent (EVH) Q1 2026 Earnings Call Transcript ↗
Evolent (EVH) Q1 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
Why Is Evolent Health (EVH) Stock Soaring Today
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 15.8% in the afternoon session after the company reported decent first... 
Via StockStory
Topics Earnings
News headline image
Evolent Health (NYSE:EVH) Misses Q1 CY2026 Revenue Estimates, But Stock Soars 5.1%
Healthcare solutions company Evolent Health (NYSE:EVH) missed Wall Street’s revenue expectations in Q1 CY2026 as sales rose 2.6% year on year to $496.2 milli... 
Via StockStory
Topics Artificial Intelligence
News headline image
Evolent Health (EVH) Reports Q1: Everything You Need To Know Ahead Of Earnings
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting results this Thursday before the bell. Here’s what investors should know. Evolent He... 
Via StockStory
News headline image
Why Evolent Health (EVH) Stock Is Up Today
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 4.1% in the afternoon session after the company reported fourth-quarte... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
Spotting Winners: Evolent Health (NYSE:EVH) And Healthcare Technology for Providers Stocks In Q4
Looking back on healthcare technology for providers stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:... 
Via StockStory
News headline image
ELV Q1 Deep Dive: Operating Discipline and AI Integration Drive Margin Expansion
Health insurance provider Elevance Health (NYSE:EVH) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 2.9% year on year to... 
Via StockStory
Topics Artificial Intelligence
News headline image
Q4 Healthcare Technology for Providers Earnings: Privia Health (NASDAQ:PRVA) Earns Top Marks
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in... 
Via StockStory
News headline image
Elevance Health (NYSE:ELV) Reports Strong Q1 CY2026
Health insurance provider Elevance Health (NYSE:EVH) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 2.9% year on year to $50.18 billion.... 
Via StockStory
News headline image
Elevance Health (ELV) Reports Q1: Everything You Need To Know Ahead Of Earnings
Health insurance provider Elevance Health (NYSE:EVH) will be reporting results this Wednesday morning. Here’s what to look for. Elevance Health missed analys... 
Via StockStory
Topics Artificial Intelligence
News headline image
3 of Wall Street’s Favorite Stocks with Open Questions
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Astrana Health, Evolent Health, Neogen, agilon health, and Fortrea Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after the government announced a surprise increase in payment rates for Medicare Advantage ... 
Via StockStory
News headline image
Evolent Health (EVH): Buy, Sell, or Hold Post Q4 Earnings?
Evolent Health has gotten torched over the last six months - since October 2025, its stock price has dropped 69.7% to $2.46 per share. This might have invest... 
Via StockStory
News headline image
RadNet, Evolent Health, Illumina, Charles River Laboratories, and Repligen Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in... 
Via StockStory
Topics Economy Government Stocks
News headline image
3 Small-Cap Stocks We’re Skeptical Of
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
3 Unprofitable Stocks We Approach with Caution
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
AMN Healthcare Services, RadNet, Evolent Health, Repligen, and Amphastar Pharmaceuticals Stocks Trade Down, What You Need To Know
Via StockStory
Topics Economy
News headline image
Evolent Health and iRhythm Shares Are Falling, What You Need To Know
A number of stocks fell in the afternoon session after a surprisingly hot wholesale inflation report fueled investor concerns about persistent price pressures. 
Via StockStory
Topics Economy Government Stocks
News headline image
Privia Health (PRVA) Q4 2025 Earnings Transcript ↗
Privia Health (PRVA) Q4 2025 Earnings Transcript 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Evolent Health (EVH) Shares Skyrocket, What You Need To Know
Shares of healthcare solutions company Evolent Health (NYSE:EVH) jumped 20.7% in the afternoon session after the company reported fourth-quarter earnings that beat expectations and provided an... 
Via StockStory
Topics Economy
News headline image
EVH Stock On Track To Open At Record Low – Here’s Why Keybanc Turned Cautious ↗
KeyBanc downgraded Evolent Health to ‘Sector Weight’ from ‘Overweight’, citing a lack of visibility in near-term EBITDA recovery. 
Via Stocktwits
News headline image
Evolent Health (NYSE:EVH) Reports Q4 CY2025 In Line With Expectations
Healthcare solutions company Evolent Health (NYSE:EVH) met Wall Street’s revenue expectations in Q4 CY2025, but sales fell by 27.5% year on year to $468.7 million. The company’s full-year revenue... 
Via StockStory
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>